Last reviewed · How we verify
AZD7268
At a glance
| Generic name | AZD7268 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects (PHASE1)
- AZD7268 Safety and Tolerability Study (PHASE2)
- Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers (PHASE1)
- Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers (PHASE1)
- Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AZD7268 CI brief — competitive landscape report
- AZD7268 updates RSS · CI watch RSS
- AstraZeneca portfolio CI